Riskpilot← Back to searchSign inGet full accessJA MED AS
ASActiveOrg 928095401Alfheimvegen 45, 9007 TromsøGeneral medical practice activities · NACE 8621Est. 20211 employees
Revenue 2024
NOK 3,5M
+9% vs 2023
EBITDA margin
30.5%
-7% vs 2023
Equity ratio
85.3%
Financial strength
Net profit 2024
NOK 809K
-6% vs 2023
| Revenue | NOK 3,5M | +9% |
| EBITDA | NOK 1,1M | -7% |
| Net profit | NOK 809K | -6% |
| Total assets | NOK 3M | +39% |
| Equity | NOK 2,5M | +47% |
| Employees | 1 | — |
Legal name
JA MED AS
Org number
928095401
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
29. desember 2021
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Allmennpraktiserende lege som fastlege ved legekontor, i kommunal legevakt og i kommunal bistilling, og annen virksomhet som lege.
Address
Alfheimvegen 45, 9007 Tromsø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 2 925 | 3 256 | 3 538 |
| Staff expenses | −0 | −823 | −1 036 | −1 076 |
| EBITDA | 0 | 1 142 | 1 166 | 1 080 |
| Depreciation & amort. | −0 | −67 | −80 | −80 |
| EBIT | 0 | 1 075 | 1 086 | 1 000 |
| Net financials | 0 | −11 | 19 | 47 |
| Profit before tax | 0 | 1 064 | 1 106 | 1 047 |
| Tax | −0 | 235 | 244 | 238 |
| Net profit | 0 | 829 | 861 | 809 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 30 | 2 877 | 2 133 | 2 967 |
| Equity | 24 | 859 | 1 720 | 2 530 |
| Long-term debt | 0 | 1 629 | 0 | 0 |
| Short-term debt | 6 | 390 | 413 | 437 |
| Total debt | 6 | 2 018 | 413 | 437 |
EBITDA margin
30.5%
This company
15.8%
Market median
+93% vs market
20212024
Equity ratio
85.3%
This company
38.2%
Market median
+123% vs market
20212024
Return on equity
32.0%
This company
18.4%
Market median
+74% vs market
20212024
Net profit margin
22.9%
This company
8.1%
Market median
+183% vs market
20212024
Asset turnover
1.19×
This company
1.12×
Market median
+6% vs market
20212024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-12-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AJ Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JA MED AS 
SENTRUM LEGEKONTOR ASBoard members of JA MED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Agnete Jørgensen | Chief Executive Officer | 0 companies |
| Sigve Andersen | Chairman | 0 companies |
| Seier Marie Andersen | Board of Directors | 0 companies |
| Storm Espolin Andersen | Board of Directors | 0 companies |